DMSO can save millions from brain and spinal injury by protecting cells and improving circulation, but the FDA has hindered its adoption.

<p>In today’s interconnected world, wireless internet access has become ubiquitous, found in nearly every coffee shop, office, and home. However, the claim that Wi-Fi signals are not benign and can influence brainwaves, leading to hypnotic effects and social engineering, requires a thorough examination.</p>
<p>The content suggests that radio-frequency (RF) radiation from Wi-Fi can interfere with brain waves, particularly extremely low frequency (ELF) waves, which can make a person unknowingly enter a suggestive state of mind. This claim is attributed to Keith Cutter, a critic of modern wireless technology.</p>
<p>To evaluate this claim, it is essential to understand the scientific basis behind the effects of RF and ELF waves on the human brain. Wi-Fi operates using radio-frequency electromagnetic fields, transmitting data via pulse-modulated RF radiation. While it is true that Wi-Fi devices emit low levels of RF radiation, the cumulative impact of this exposure over time is a subject of ongoing research.</p>
<p>The content highlights the effect of ELF waves, which range from approximately 3 to 30 Hz, overlapping with the natural oscillation frequencies of the human brain. The brain’s electrical activity is divided into different frequency bands, each associated with different states of consciousness and mental function. The concern is that the 10Hz ELF pulses emitted by Wi-Fi beacons can induce brainwave entrainment, synchronizing brainwaves to an external frequency.</p>
<p>Brainwave entrainment refers to the synchronization of brainwaves to an external frequency. When the brain is exposed to a consistent external stimulus at a particular frequency, such as the 10Hz signal emitted by Wi-Fi, it can shift its own natural brainwave patterns to match. At 10Hz, the brain enters a more relaxed state, akin to alpha waves, which corresponds to reduced cortical activity.</p>
<p>However, the claim that prolonged exposure to the 10Hz ELF signal can create a “suggestible state,” making the brain more susceptible to external influences, is not supported by scientific evidence. While brainwave entrainment is a recognized phenomenon, its potential for mind control or social engineering is speculative and lacks empirical support.</p>
<p>Another concern raised is the potential for Wi-Fi to have a “memory effect” on body tissues, leading to long-term physical changes or health conditions. This claim is also not supported by reliable scientific studies. The concept of “trauma memory” in the body is a psychological concept, and its application to electromagnetic radiation is not backed by evidence.</p>
<p>In conclusion, the claim that Wi-Fi can influence brainwaves and has potential for hypnotic effects and social engineering is largely unsupported by scientific evidence. While there are legitimate concerns about the effects of electromagnetic radiation, the specific claims made in the content are not backed by reliable studies.</p>
<p>References:</p>
<p>1. <a href="https://www.who.int/india/health-topics/electromagnetic-fields">Electromagnetic fields and public health: mobile phones</a> - World Health Organization</p>
<p>2. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504984/">Health effects of electromagnetic fields: EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses</a> - Belpomme D, Hardell L, Belyaev I, Burgio E, Carpenter DO</p>
<p>3. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10198548/">Brainwave entrainment: a review and quantitative analysis</a> &nbsp;- Huang TL, Charyton C</p>

Claim Review: Wi-Fi Can Influence Brainwaves and Has Potential for Hypnotic Effects and Social Engineering

<h2>Introduction</h2>
<p>The recent approval of the ACAM2000 vaccine for monkeypox by the Food and Drug Administration (FDA) has sparked controversy due to its acknowledged risks, particularly cardiac inflammation. This article aims to review the claim that the FDA approved the vaccine despite knowing its dangers.</p>
<h2>Background</h2>
<p>The ACAM2000 vaccine, developed by Emergent BioSolutions, was initially approved for smallpox in 2007. On August 29, 2024, the FDA expanded its approval to include individuals at high risk for monkeypox, such as members of the LGBT community.</p>
<h2>Claim Analysis</h2>
<p>The claim suggests that the FDA approved the ACAM2000 vaccine despite knowing its risks. The FDA's medication guide for ACAM2000 lists numerous side effects, including the potential spread of the live vaccinia virus to close contacts and serious complications such as myopericarditis (heart lining and/or muscle inflammation).</p>
<p>According to Karl Jablonowski, a senior research scientist at Children's Health Defense, the risk of cardiac inflammation is significant, with estimates ranging from one in 2,000 to one in 175 vaccinations. Dr. Meryl Nass, an internist and biological warfare expert, also highlighted the CDC's acknowledgment of this risk during a June 2022 meeting.</p>
<p>However, it is crucial to understand the FDA's approval process. The agency evaluates the benefits and risks of a vaccine, especially in the context of public health emergencies. The approval of ACAM2000 for monkeypox was likely based on the assessment that the benefits outweigh the risks for high-risk individuals.</p>
<h2>Scientific Evidence</h2>
<p>The risk of myopericarditis associated with ACAM2000 is well-documented. A study published in the <a href="https://academic.oup.com/aje/article-abstract/160/7/642/136637?redirectedFrom=PDF#google_vignette">New England Journal of Medicine</a> &nbsp;reported cases of myopericarditis following smallpox vaccination, highlighting the need for careful monitoring and risk assessment.</p>
<p>The FDA's approval process involves rigorous evaluation of clinical data and consideration of public health needs. While the risks are acknowledged, the decision to approve the vaccine reflects a balance between these risks and the potential benefits in preventing monkeypox.</p>
<h2>Conclusion</h2>
<p>The claim that the FDA approved the ACAM2000 vaccine for monkeypox despite acknowledging its dangerous side effects is partially true. While the vaccine has known risks, the FDA's approval process considers the benefits versus the risks in the context of public health emergencies. It is essential for individuals to be informed about the potential side effects and for healthcare providers to monitor vaccinated individuals closely.</p>

Claim Review: FDA Approves Monkeypox Vaccine Despite Known Risks

<h1>Claim Review: Cellphone Radiation and Brain Cancer</h1>
<p>The claim that cellphone radiation may cause brain cancer has been a topic of debate for many years. Several peer-reviewed studies have been conducted to investigate this claim, but the evidence is not conclusive. While some studies show a link between cellphone radiation and brain cancer, others do not.</p>
<p>A recent study published in Environmental Health analyzed 24 studies and found significantly higher risks for malignant brain tumors, meningioma, and glioma on the side of the head where cellphones were held. The study also found that heavy, long-term cellphone use was linked to an increased risk of glioma. This study brings the number of meta-analyses published since 2016 linking cellphone radiation to an increased risk of brain cancer to seven.</p>
<p>However, a recent WHO-led study claimed there’s no evidence of a link between cellphone radiation and brain cancer. Some experts have suggested that the WHO picked industry-biased researchers to conduct its review. Lennart Hardell, a leading scientist who found a link between cellphone use and gliomas, agreed that the WHO study authors should be responsible for their fraudulent behavior violating human health and the environment.</p>
<p>Brain tumor rates are on the rise in Denmark, which is known for its high-quality tracking of cancer cases. This data contradicts the notion that the rate of brain tumors isn’t on the rise, which has been used to claim that cellphone use is not linked to an increased risk of brain tumors or cancers in general. A 2023 study on brain cancer rates worldwide from 1990-2019 found a significant rise in brain cancer among both men and women in nearly all parts of the world.</p>
<p>The U.S. Food and Drug Administration (FDA) claims there’s not enough scientific evidence to link cellphone use to health problems, including brain cancer. However, the FDA rejected the findings of a $30 million study it commissioned on the topic, which concluded there was 'clear evidence' that male rats exposed to high levels of wireless radiation like that used in 2G and 3G cellphones developed cancerous heart tumors, and 'some evidence' of tumors in the brain and adrenal gland of exposed male rats.</p>
<p>In conclusion, while some studies suggest a link between cellphone radiation and brain cancer, the evidence is not conclusive. The World Health Organization and other health agencies have not found sufficient evidence to support this claim. More research is needed to fully understand the potential risks.</p>
<h2>References</h2>
<ul>
  <li><a href="https://ehjournal.biomedcentral.com/articles/10.1186/s12940-024-01117-8">Relationship between radiofrequency-electromagnetic radiation from cellular phones and brain tumor: meta-analyses using various proxies for RF-EMR exposure-outcome assessment</a> - Jinyoung Moon, Jungmin Kwon &amp; Yongseok Mun, Environmental Health volume 23, Article number: 82 (2024)&nbsp;</li>
</ul>

Claim Review: Cellphone Radiation and Brain Cancer

<p>The claim that drug research has not significantly advanced in the past half-century, with most new drugs being variations of existing ones, was made in an article published on The Expose on August 28, 2024. This claim is based on an essay by Dr. Vernon Coleman, originally written 50 years ago and republished in 1975.</p>
<p>To evaluate this claim, it is essential to consider the context and advancements in pharmaceutical research over the past five decades.</p>
<h2>Historical Context</h2>
<p>Dr. Coleman's essay, written in the 1970s, highlighted the trend of diminishing originality in drug development. He noted that research efforts were concentrated on cancer, cardiovascular disorders, viral diseases, and psychological disorders. However, progress was hindered by the complex nature of these conditions and a lack of comprehensive understanding of biochemistry.</p>
<h2>Advancements in Drug Research</h2>
<p>While it is true that many new drugs are variations of existing ones, significant advancements have been made in pharmaceutical research. For instance, the development of targeted therapies for cancer, such as monoclonal antibodies and kinase inhibitors, has revolutionized cancer treatment. These therapies are designed to specifically target cancer cells, reducing side effects and improving patient outcomes. A study published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776980/">Journal of Clinical Oncology</a> highlights the impact of targeted therapies on cancer treatment.</p>
<p>In the field of cardiovascular disorders, the introduction of statins in the late 1980s has significantly reduced the risk of heart disease. Statins work by lowering cholesterol levels, which is a major risk factor for cardiovascular diseases. A review published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967093/">Journal of the American College of Cardiology</a> discusses the efficacy and safety of statins.</p>
<p>For viral diseases, the development of antiviral drugs has been crucial. For example, the introduction of antiretroviral therapy (ART) for HIV has transformed the disease from a fatal condition to a manageable chronic illness. A study published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843618/">Lancet</a> discusses the impact of ART on HIV treatment.</p>
<p>In the field of psychological disorders, the development of selective serotonin reuptake inhibitors (SSRIs) has been a significant advancement. SSRIs are a class of antidepressants that work by increasing the levels of serotonin in the brain. A review published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172306/">Journal of Clinical Psychiatry</a> discusses the efficacy and safety of SSRIs.</p>
<h2>Challenges in Drug Research</h2>
<p>Despite these advancements, drug research faces significant challenges. The complexity of diseases, the need for a comprehensive understanding of biochemistry, and the ethical considerations in drug development are ongoing issues. Additionally, the high cost of drug development and the need for extensive clinical trials can hinder progress.</p>
<h2>Conclusion</h2>
<p>The claim that drug research has not significantly advanced in the past half-century is partially true but oversimplifies the complexities and advancements in pharmaceutical research. While many new drugs are variations of existing ones, significant advancements have been made in targeted therapies for cancer, statins for cardiovascular disorders, antiviral drugs for viral diseases, and SSRIs for psychological disorders. However, drug research continues to face significant challenges, and ongoing efforts are needed to address these issues.</p>

Claim Review: Drug Research Stagnation Over the Past Half-Century

If you want to replace an existing title on a portal and you want the replaced title to be visible to you and your followers.

Move the mouse over the title and make a right click.

Select Remedia -> Alternate Title from the menu

In the pop-up window, enter a new title that you like.

The blue icon copies the existing title into the input field, so you don't have to type everything...

By pressing Submit, the title will be replaced, which will be visible to you and others who visit the pages.

(There is a possibility that you will have to reload the page for the changes to be visible)

You can contact one of the fact-checking organizations.

Claim rated as -> Choose from false to true

Add claimer -> Opens a pop-up window that allows you to search for existing people already registered in the system or to create a new profile of that person.

Claimed At -> Enter the link to the page where the claim was found. You can add more places and link more claim authors

Short description -> short content that is seen when sharing articles on social networks

Field for entering the content of the article.

After the article is published, it will be visible on the Remedia social network and to everyone who has the Remedia Chrome extension installed

And you can engage in debunking yourself.

CAUTION! Abusing the platform is not allowed, entering unverified, misleading or untrue content will result in the deletion of the entire account with all content

Canonical -> If you enter content that already exists somewhere (your property), you can enter a link and Remedia will try to enter the content in the provided fields.

Featured image -> Image that is displayed when you share an article on other social networks.

Write your title -> Enter the title of the article

The claim being reviewed -> Enter the claim here, but BEWARE! An assertion is not the entire statement someone has made, but something concise and unambiguous. Check the claim entry multiple times as each change will create a new claim in the system.

Claim made on -> date when someone published the claim.

After installing the Chrome extension, you can log in and use advanced functionalities. One of them is 'Dislike'.

By right-clicking on an article, the options provided by the Remedia extension are opened, by selecting Dislike, the article will become more transparent and less visible.

Your action will be visible to you and all people who follow you!

Alternate Title

1. Log in to the Remedia social network with a Google or Facebook account (link above right).

2. Install the Chrome extension (if you didn't)

4. Enter the email you used to open your Google or Facebook account. Submit.

5. After the input field appears, rewrite the code. Accept.

That's it! Now you can use the advanced functions of the Remedia Chrome extension.

Alternate Titles

Remedia's work so far:

Remedia, the best thing that happened to media!

On the Feed page, you can enter Status, Opinion and Claim Review

It is enough to enter the title, short description and content.

Below the fields for entering content, you will find fields for entering links. By entering page links in these fields, you 'show' the Chrome extension on which pages to display your content

Press Publish to publish your opinion. (It may be necessary to wait a moment while all links are generated)

Claim: "DMSO can save millions from brain and spinal injury by protecting cells and improving circulation, but the FDA has hindered its adoption." is

Content you might like: